{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:58Z","timestamp":1786119298429,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/fjc.0b013e3181a717f7","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T07:16:47Z","timestamp":1244791007000},"page":"468-473","source":"Crossref","is-referenced-by-count":25,"title":["Beneficial Effects of Torasemide on Systolic Wall Stress and Sympathetic Nervous Activity in Asymptomatic or Mildly Symptomatic Patients With Heart Failure: Comparison With Azosemide"],"prefix":"10.1097","volume":"53","author":[{"given":"Ken","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hirashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian Wu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzo","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210208","first-page":"e154","article-title":"ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"R2-7-20210208","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"R3-7-20210208","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"key":"R4-7-20210208","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cardiores.2005.05.023","article-title":"Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.","volume":"68","author":"Yoshida","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R5-7-20210208","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(03)00765-4","article-title":"Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD).","volume":"42","author":"Domanski","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R6-7-20210208","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cardfail.2006.03.006","article-title":"Diuretic use, progressive heart failure, and death in patients in the DIG study.","volume":"12","author":"Domanski","year":"2006","journal-title":"J Card Fail"},{"issue":"Suppl 1","key":"R7-7-20210208","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/00005344-200110001-00017","article-title":"Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.","volume":"38","author":"Tsutsui","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"R8-7-20210208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy.","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"key":"R9-7-20210208","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torasemide compared with furosemide therapy for patients with heart failure.","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"key":"R10-7-20210208","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study.","volume":"4","author":"Cosin","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"R11-7-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R12-7-20210208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90812-5","article-title":"Anti-aldosteronergic effect of torasemide.","volume":"205","author":"Uchida","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"R13-7-20210208","doi-asserted-by":"crossref","first-page":"L45","DOI":"10.1016\/S0024-3205(98)00265-3","article-title":"Torasemide inhibits aldosterone secretion in vitro.","volume":"63","author":"Goodfriend","year":"1998","journal-title":"Life Sci"},{"key":"R14-7-20210208","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0002-8703(89)90291-3","article-title":"The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.","volume":"118","author":"Francis","year":"1989","journal-title":"Am Heart J"},{"key":"R15-7-20210208","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.HYP.24.5.571","article-title":"Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.","volume":"24","author":"Wang","year":"1994","journal-title":"Hypertension"},{"key":"R16-7-20210208","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients.","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc Res"},{"key":"R17-7-20210208","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI108079","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle.","volume":"56","author":"Grossman","year":"1975","journal-title":"J Clin Invest"},{"key":"R18-7-20210208","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.CIR.65.1.99","article-title":"Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application.","volume":"65","author":"Reichek","year":"1982","journal-title":"Circulation"},{"key":"R19-7-20210208","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","article-title":"Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.","volume":"49","author":"Levine","year":"1982","journal-title":"Am J Cardiol"},{"key":"R20-7-20210208","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"R21-7-20210208","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.","volume":"50","author":"Begona","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R22-7-20210208","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0735-1097(97)00390-2","article-title":"Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: critical role of left ventricular systolic function.","volume":"30","author":"Yamamoto","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R23-7-20210208","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0024-3205(76)90210-1","article-title":"Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man.","volume":"18","author":"Lake","year":"1976","journal-title":"Life Sci"},{"key":"R24-7-20210208","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"R25-7-20210208","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0735-1097(95)00332-0","article-title":"Adverse consequences of high sympathetic nervous activity in the failing human heart.","volume":"26","author":"Kaye","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R26-7-20210208","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1053\/euhj.2000.2407","article-title":"Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.","volume":"22","author":"Brunner-La Rocca","year":"2001","journal-title":"Eur Heart J"},{"issue":"pt 1","key":"R27-7-20210208","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.78.5.1192","article-title":"Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.","volume":"78","author":"Henderson","year":"1988","journal-title":"Circulation"},{"key":"R28-7-20210208","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/hrt.2005.079764","article-title":"Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"key":"R29-7-20210208","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","article-title":"Aldosterone production is activated in failing ventricle in humans.","volume":"103","author":"Mizuno","year":"2001","journal-title":"Circulation"},{"key":"R30-7-20210208","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FJC.0b013e3181a717f7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:21Z","timestamp":1786038921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200906000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181a717f7","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}